%0 Journal Article
%T Ibrutinib as an antitumor immunomodulator in patients with refractory chronic lymphocytic leukemia
%A Carolina Cubillos-Zapata
%A Eduardo L¨®pez-Collazo
%A Enrique Hern¨˘ndez-Jim¨¦nez
%A Jose AvendaŁżo-Ortiz
%A Ra¨˛l C¨®rdoba
%A Rebeca P¨¦rez de Diego
%A Victor Toledano
%J Archive of "Oncoimmunology".
%D 2016
%R 10.1080/2162402X.2016.1242544
%K CLL patients
%K ibrutinib treatment
%K immune response
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5213769/